T1	TimeInfo 0 3	26J
T3	Condition 45 56	Rejektionen
T4	DiagLab 57 61	NiBi
T5	TimeInfo 62 74	vor 7 Jahren
T6	Condition 76 80	FSGS
T8	LabValues 140 144	Krea
T9	Measure 145 148	1,6
T10	Measure 150 157	geringe
T11	LabValues 158 160	PU
A1	Factuality T3 negative
T14	Tx_high 0 12	26J nach NTX
T2	Process 30 37	Verlauf
T15	HealthState 21 29	stabiler
R1	has_State arg1:T2 arg2:T15	
R2	has_TimeInfo arg1:T4 arg2:T5	
R3	has_Measure arg1:T8 arg2:T9	
R4	has_Measure arg1:T11 arg2:T10	
T7	Medication 88 90	IS
T12	Medication 137 139	IS
A2	Risk T14 increase_risk_factor
A3	Risk T2 decrease_symptom
A4	Risk T3 decrease_risk_factor
A5	Risk T6 increase_risk_factor
R5	has_State arg1:T4 arg2:T6	
A6	Risk T7 decrease_risk_factor
T13	Measure 81 87	Triple
R6	has_Measure arg1:T7 arg2:T13	
T16	Condition 99 106	ED PTLD
A7	Risk T16 symptom
T18	Measure 127 136	Reduktion
R7	has_Measure arg1:T12 arg2:T18	
A8	Risk T12 increase_risk_factor
A9	Risk T8 decrease_symptom
A10	Risk T11 decrease_symptom
T19	LabValues 167 170	DSA
A11	Factuality T19 speculated
A12	Risk T19 increase_risk_factor
T20	Measure 171 173	DQ
R8	has_Measure arg1:T19 arg2:T20	
T21	Conclusion 174 228	trotz langer TX Zeit Einschätzung für niedriges Risiko
T22	Temporal 0 56	26J nach NTX, bisher stabiler Verlauf, keine Rejektionen
A13	Temporal_Element T22 past_present
T23	Temporal 57 80	NiBi vor 7 Jahren: FSGS
A14	Temporal_Element T23 past
T24	Temporal 81 90;91 106	Triple IS Problem ED PTLD
A15	Temporal_Element T24 present
T25	Temporal 108 139	Therapie und vorr. Reduktion IS
A16	Temporal_Element T25 present
T26	Temporal 140 173	Krea 1,6, geringe PU, V.a. DSA DQ
A17	Temporal_Element T26 present
